Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 3,878,000 | 3,661,000 | 3,883,000 | 3,595,000 | 3,786,000 |
| Cost of Goods | 2,082,000 | 2,079,000 | 2,113,000 | 1,926,000 | 1,992,000 |
| Gross Profit | 1,796,000 | 1,582,000 | 1,770,000 | 1,669,000 | 1,794,000 |
| Operating Expenses | 2,450,000 | 1,595,000 | 2,722,000 | 1,250,000 | 2,744,000 |
| Operating Income | -654,000 | -13,000 | -952,000 | 419,000 | -950,000 |
| Other Income | -268,000 | -259,000 | -247,000 | -252,000 | -210,000 |
| Pre-tax Income | -922,000 | -272,000 | -1,199,000 | 167,000 | -1,160,000 |
| Income Tax | -16,000 | -19,000 | 148,000 | 107,000 | -900,000 |
| Net Income Continuous | -906,000 | -253,000 | -1,347,000 | 60,000 | -260,000 |
| Minority Interests | -35,000 | -33,000 | -32,000 | 3,000 | -27,000 |
| Net Income | $-871,000 | $-220,000 | $-1,314,000 | $55,000 | $-232,000 |
| EPS Basic Total Ops | -0.78 | -0.20 | -1.18 | 0.05 | -0.21 |
| EPS Basic Continuous Ops | -0.81 | -0.23 | -1.21 | 0.05 | -0.23 |
| EPS Diluted Total Ops | -0.78 | -0.20 | -1.18 | 0.05 | -0.21 |
| EPS Diluted Continuous Ops | -0.81 | -0.23 | -1.21 | 0.05 | -0.23 |
| EBITDA(a) | $-354,000 | $291,000 | $-646,000 | $740,000 | $-592,000 |